Prelude Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $40k | 9.4k | 4.27 |
| 2023-09-30 | $54k | 17k | 3.09 |
| 2023-06-30 | $42k | 9.3k | 4.50 |
| 2023-03-31 | $8.0k | 1.4k | 5.74 |
| 2022-12-31 | $8.0k | 1.3k | 6.17 |
| 2022-06-30 | $11k | 2.0k | 5.41 |
| 2022-03-31 | $64k | 9.3k | 6.90 |
| 2021-12-31 | $91k | 7.2k | 12.54 |
| 2021-03-31 | $273k | 6.3k | 43.43 |
| 2020-12-31 | $1.8M | 25k | 72.46 |